FA
STIM icon

Fermata Advisors’s Neuronetics STIM Stock Holding History

Fermata Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,849
Closed -$28.8K – 278
2026
Q1 		$28.8K Buy
19,849
+6
+0% +$10 0.01% 232
2025
Q4 		$27.4K Buy
19,843
+5,500
+38% +$11.5K 0.01% 216
2025
Q3 		$39.2K Sell
14,343
-422
-3% -$1.5K 0.01% 210
2025
Q2 		$51.5K Buy
+14,765
New +$58.3K 0.01% 220

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fermata Advisors's STIM Position: Q2 2026 in Review

Fermata Advisors sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 19,849 shares — an estimated $28.8K sold.

Fermata Advisors first reported a position in STIM in Q2 2025 and held it in 4 quarters. The position peaked at $51.5K in Q2 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Fermata Advisors reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Fermata Advisors sold 19,849 Neuronetics shares in Q2 2026, an estimated $28.8K.
  • Fermata Advisors first reported a position in Neuronetics in Q2 2025 and held it in 4 quarters.
  • Fermata Advisors's Neuronetics position peaked at $51.5K in Q2 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Fermata Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.